On November 9, 2021 Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage oncology company, developing new precision medicine treatment options for cancer patients in indications with the greatest unmet medical need including KRAS-mutated colorectal cancer, pancreatic cancer, and castrate-resistant prostate cancer, reported that company management will present and participate in virtual 1×1 investor meetings at the Jefferies London Healthcare Conference and the Piper Sandler 33rd Annual Healthcare Conference, taking place November 16 – 19, 2021, and November 29 – December 2, 2021, respectively (Press release, Cardiff Oncology, NOV 9, 2021, View Source [SID1234594986]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details on the presentations can be found below.

Jefferies London Healthcare Conference

Presentation Date:

Available on-demand beginning at 8:00 AM GMT (3:00 AM ET) on November 18, 2021

Piper Sandler 33rd Annual Healthcare Conference

Presentation Date:

Available on-demand beginning at 10:00 AM ET on November 22, 2021

Webcasts of the presentations will be available by visiting the "Events" section of the Cardiff Oncology website and will be archived for 30 days.